I am a pediatric intensivist and neurointensivist at Lurie Children's Hospital. As an intensivist, I provide clinical care for critically ill patients in the med-surg PICU. As a neurointensivist, I provide consultative services for neurologic emergencies and neurologic complications of critical illness in the cardiac and med-surg ICUs.

As Medical Director and Director of Innovation (IGNITE Innovation) and Strategy for the Pediatric Intensive Care Unit, my research is focused on generating innovative solutions to improve patient outcomes and quality of care, while fostering dynamic strategies to minimize waste and optimize resources. In particular, through IGNITE Innovation I build multi-disciplinary innovative strategies and platforms for novel idea generation, solutions for costly systems including patient care processes, and creative approaches to forwarding patient safety, quality and care delivery for value formation.

My clinical interest include congenital heart defects and cardiac imaging including pediatric and fetal echocardiography. My specific interest include perinatal cardiology and cardiac care of patients with Turner Syndrome. I work with the Chicago Institute for Fetal Health to provide perinatal cardiology expertise. I co-direct the multidisciplinary Turner's syndrome clinic at Lurie. My research interests are in evaluating outcomes in congenital heart defects; with special focus on single ventricle heart defect and Fontan palliation.

Dr. Myers is the Fellowship Director of Neonatal-Perinatal Medicine at Lurie Children's Hospital and Northwestern University. He trained as a pediatrics resident and neonatology fellow at the University of Chicago. Dr. Myers also serves as the webmaster for the Organization of Neonatal Program Directors.

Dr. O'Neill completed her undergraduate degree in psychology and pre-professional studies at the University of Notre Dame, her medical school degree at the Johns Hopkins University School of Medicine, a general pediatrics residency at Lurie Children's Hospital in Chicago, and a neurodevelopmental disabilities combined residency/fellowship at the Kennedy Krieger Institute and Johns Hopkins Hospital in Baltimore, MD. She is board certified in both General Pediatrics and Neurology with special qualifications in Child Neurology. She enjoys practicing medicine in a multidisciplinary environment whe...

My primary research interest involves neonatal neuroprotection. Neuroprotection with the application of therapeutic hypothermia in term and near-term infants with perinatal brain injury/neonatal encephalopathy, and neonatal stroke. I am the Site PI for Preterm Epo Neuroprotection Trial (PENUT Trial). A Multi-Center, Randomized Placebo-Controlled Phase III 940-subject Trial of Erythropoietin for the Neuroprotection of Extremely Low Gestational Age Neonates (ELGANs); 2013 - 2018.

Current clinical practice utilizes a multidisciplinary team approach to the diagnosis and treatment of pediatric epilepsy and comorbidities. Dr. Millichap has over 40 peer-reviewed medical publications and serves as the Section Editor of the Resident and Fellow Section of the journal Neurology and the Editor of Pediatric Neurology Briefs. As a member of the academic faculty of Northwestern University, he is involved in the education of trainees and grant-funded clinical research concerning epileptic encephalopathies and epilepsy genetics. <a href="http://orcid.org/0000-0002-0798-0131" title="O...

My primary research interest is in lung repair after acute injury with a focus on TGF-beta mediated signaling. We have identified mitochondrial generated reactive oxygen species as important in TGF-bête mediated gene expression and are working to identify novel therapeutic targets in this pathway. We are also interested in modulating the ubiquitin-proteosomal pathway as a therapeutic target for tissue fibrosis. I have a clinical translational interest in Cystic Fibrosis. I am the site co-PI for the CF Foundation sponsored clinical trial network, The Therapeutic Development Network. I am also i...

Application of Hematopoietic Stem Cell Transplantation to treat pediatric diseases--hematologic and immunologic diseases, select congenital metabolic diseases as well as high-risk malignancies. Expand the indications for Stem Cell transplantation as cellular therapy for other diseases/organ dysfunction. Utilize Stem Cell Transplantation as a platform for cellular therapies for inherited and acquired diseases.